This is the
talk page for discussing improvements to the
Hydroxychloroquine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2Auto-archiving period: 180 days |
This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
The
contentious topics procedure applies to this page. This page is related to
COVID-19, broadly construed, which has been
designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Hydroxychloroquine.
|
This article has been viewed enough times in a single week to appear in the Top 25 Report. The week in which this happened: |
Daily pageviews of this article
A graph should have been displayed here but
graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at
pageviews.wmcloud.org |
A note on WP:MEDRS: Per this Wikipedia policy, we must rely on the highest quality secondary sources and the recommendations of professional organizations and government bodies when determining the scientific consensus about medical treatments.
Evidence of efficacy for ivermectin is inconclusive. It should not be used outside of clinical trials.( May 2021, June 2021, June 2021, July 2021, July 2021) ( WHO, FDA, IDSA, ASHP, CDC, NIH)
Neither hydroxychloroquine nor chloroquine should be used, either alone or in combination with azithromycin, in inpatient or outpatient settings.( July 2020, Aug 2020, Sep 2020, May 2021) ( WHO, FDA, IDSA, ASHP, NIH)
17.000 deaths in just 6 countries attributable to hydroxychloroquine: https://www.sciencedirect.com/science/article/pii/S075333222301853X
See also https://www.sudouest.fr/sante/coronavirus/covid-19-selon-une-etude-l-hydroxychloroquine-serait-responsable-de-pres-de-17-000-morts-dont-199-en-france-18011353.php (in French). -- Randykitty ( talk) 09:37, 6 January 2024 (UTC)
This
edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
Change "Neither drug prevents SARS-CoV-2 infection." to "Neither drug has been useful to prevent or treat SARS-CoV-2 infection." Add reference to Cochrane review: Singh B, Ryan H, Kredo T, Chaplin M, Fletcher T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD013587. DOI: 10.1002/14651858.CD013587.pub2. Tkesteman ( talk) 03:54, 27 February 2024 (UTC)
This is the
talk page for discussing improvements to the
Hydroxychloroquine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2Auto-archiving period: 180 days |
This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
The
contentious topics procedure applies to this page. This page is related to
COVID-19, broadly construed, which has been
designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Hydroxychloroquine.
|
This article has been viewed enough times in a single week to appear in the Top 25 Report. The week in which this happened: |
Daily pageviews of this article
A graph should have been displayed here but
graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at
pageviews.wmcloud.org |
A note on WP:MEDRS: Per this Wikipedia policy, we must rely on the highest quality secondary sources and the recommendations of professional organizations and government bodies when determining the scientific consensus about medical treatments.
Evidence of efficacy for ivermectin is inconclusive. It should not be used outside of clinical trials.( May 2021, June 2021, June 2021, July 2021, July 2021) ( WHO, FDA, IDSA, ASHP, CDC, NIH)
Neither hydroxychloroquine nor chloroquine should be used, either alone or in combination with azithromycin, in inpatient or outpatient settings.( July 2020, Aug 2020, Sep 2020, May 2021) ( WHO, FDA, IDSA, ASHP, NIH)
17.000 deaths in just 6 countries attributable to hydroxychloroquine: https://www.sciencedirect.com/science/article/pii/S075333222301853X
See also https://www.sudouest.fr/sante/coronavirus/covid-19-selon-une-etude-l-hydroxychloroquine-serait-responsable-de-pres-de-17-000-morts-dont-199-en-france-18011353.php (in French). -- Randykitty ( talk) 09:37, 6 January 2024 (UTC)
This
edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
Change "Neither drug prevents SARS-CoV-2 infection." to "Neither drug has been useful to prevent or treat SARS-CoV-2 infection." Add reference to Cochrane review: Singh B, Ryan H, Kredo T, Chaplin M, Fletcher T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD013587. DOI: 10.1002/14651858.CD013587.pub2. Tkesteman ( talk) 03:54, 27 February 2024 (UTC)